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Abstract
Increased availability of data and accessibility of computational tools in recent years have created
unprecedented opportunities for scientific research driven by statistical analysis. Inherent limita-
tions of statistics impose constrains on reliability of conclusions drawn from data but misuse of
statistical methods is a growing concern. Significance, hypothesis testing and the accompanying
P-values are being scrutinized as representing most widely applied and abused practices. One line
of critique is that P-values are inherently unfit to fulfill their ostensible role as measures of scien-
tific hypothesis’s credibility. It has also been suggested that while P-values may have their role as
summary measures of effect, researchers underappreciate the degree of randomness in the P-value.
High variability of P-values would suggest that having obtained a small P-value in one study, one is,
nevertheless, likely to obtain a much larger P-value in a similarly powered replication study. Thus,
“replicability of P-value” is itself questionable. To characterize P-value variability one can use pre-
diction intervals whose endpoints reflect the likely spread of P-values that could have been obtained
by a replication study. Unfortunately, the intervals currently in use, the P-intervals, are based on
unrealistic implicit assumptions. Namely, P-intervals are constructed with the assumptions that
imply substantial chances of encountering large values of effect size in an observational study, which
leads to bias. The long-run coverage property provided by P-intervals is similar in interpretation
to the coverage provided by the classical confidence intervals, but the endpoints of any particular
interval lack interpretation as probabilistic bounds for possible spread of future P-values that may
have been obtained in replication studies. As an alternative to P-intervals, we develop a method
that gives researchers flexibility by providing them with the means to control these assumptions.
Unlike endpoints of P-intervals, endpoints of our intervals are directly interpreted as probabilistic
bounds for replication P-values and are resistant to selection bias contingent upon approximate
prior knowledge of the effect size distribution. We showcase our approach by its application to
P-values reported for five psychiatric disorders by the Psychiatric Genomics Consortium group.
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Introduction
Poor replicability has been plaguing observational studies. The “replicability crisis” is largely
statistical and while there are limits to what statistics can do, a serious concern is misapplication
of statistical methods. Significance testing and P-values are often singled out as major culprits not
only because these concepts are easy to misinterpret but for purported inherent flaws. It has been
suggested that variability of P-values is underappreciated in the sense that when a small P-value
is obtained by a given study, researchers commonly suppose that a similarly designed independent
replication study is likely to yield a similarly small P-value. Great variability of replication P-values
casts doubt on validity of conclusions derived by a study at hand and implies lack of confidence in
possible outcomes of any follow-up studies. It has been suggested that in reality one should expect
a great uncertainty in what replication P-value will be and special prediction intervals for P-values
(“P-intervals”) have been employed to characterize that uncertainty.1–5
P-intervals have been presented as an objective measure of P-value variability, as opposed to
subjective judgements reported by researchers in surveys, with the conclusion that the subjective
estimates are too narrow and therefore researchers tend to underestimate randomness of replication
P-values.2 While P-intervals have been used mainly as a tool to elucidate flaws of P-values, they
have also been promoted as important additions to P-values themselves in publications supportive
of P-values as being useful and universal summaries of statistical tests. It has been suggested that
P-intervals improve P-value interpretability, especially in large-scale genomic studies with many
tests and other studies utilizing modern high-throughput technologies.4,5
The distribution of P-value and thus its variability is easily characterized analytically for the
basic test statistics and depends on a measure of effect size such as the value of the relative risk
(RR) of disease given exposure vs. nonexposure to a pollutant. Effect sizes themselves can be
thought as arising from a distribution, e.g., see Equation 11 in Kuo et al. 2015,6 in which case
the P-value distribution becomes a weighted average, i.e., a marginal distribution over all possible
values of the effect with their respective probabilities as weights. The idea behind the P-intervals
is that even without such “prior” knowledge on possible values of the effect size, one can take at
face value the magnitude of an obtained P-value (Pobt). In other words, there is information about
the magnitude of the effect size contained in the magnitude of Pobt which can be used to make
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predictions about a P-value obtained in a replication study, denoted as Prep.
The following quote from Cumming, 20081 gets to the heart of the matter succinctly: “This
article shows that, if an initial experiment results in two-tailed p = .05, there is an 80% chance
the one-tailed p value from a replication will fall in the interval (.00008, .44) [...] Remarkably, the
interval – termed a p interval – is this wide however large the sample size.” An equivalent statement
appears in a Nature Methods letter by Halsey and colleagues: “regardless of the statistical power of
an experiment, if a single replicate returns a P value of 0.05, there is an 80% chance that a repeat
experiment would return a P value between 0 and 0.44.”3 Both statements make use of a specific
value, P=0.05 for which the interval is constructed and the endpoints of that interval are described
explicitly as probability bounds for possible values of replication P-values. However, these P-
intervals are derived as classical prediction intervals based on the normal test statistic (Z-statistic)
and as such only provide long-run β% coverage, meaning that β% of P-intervals constructed around
different values of Pobt over a large number of studies would contain the respective replication P-
values. It is important that by construction, the coverage is guaranteed as an average over many
studies only without any restrictions on the value of Pobt.
Once a P-interval is constructed for a particular Pobt, its endpoints cannot be interpreted
as statistical bounds for a replication P-value, unless specific conditions are met regarding the
likelihood of all possible values for the standardized effect size, such as the difference between
two sample means over the standard deviation, δ=(µ1 − µ2)/σ. If one took a large collection of
observational studies and had access to the actual, population values of δ, then the distribution of
these values would have had the variance that we denote by s20. When a P-interval is constructed
assuming the sample size N , its endpoints can be interpreted as probability bounds for Prep only
when N × s20 approaches infinity. This is equivalent to the assumption that the expected value of
the Z-statistic for a randomly selected study of size N can be anywhere from −∞ to ∞ with equal
probability.
How large can N × s20 be assumed to be realistically? Genetic epidemiology and other obser-
vational studies routinely test hypotheses that can be viewed conceptually as a comparison of two
sample means. Exposure to an environmental factor or genetic effect of a locus on susceptibility
to disease are examples where the presence of effect implies a difference in mean values between
subjects with and without disease. In these examples, the effect size can be measured by the
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log of odds ratio, log(OR). Expecting the majority of effect sizes to be small and the direction
of effect to be random, log(OR) can be described by a zero-centered, bell-shaped distribution.
It can be shown (Methods section) that the value δ for a given value of log(OR) cannot exceed
log(OR)/
[
2
√
2 + (1 + OR)/
√
OR
]
. This implies that a considerable spread of δ values is unreal-
istic. For example, OR=4 gives the maximum possible value for δ to be about 1/3. Even a very
large value OR=10 results in max(δ) ≈ 1/2. Such large odds ratios are very rarely encountered
in epidemiological studies, suggesting that realistic variance values s20 cannot be very large. Fur-
ther, as detailed in Methods section, the maximum possible value of δ for any OR cannot exceed
≈0.663. This bound places further restrictions on realistic and maximum possible values of the
prior variance s20, because the prior distribution has to vanish at that bound.
Genetic epidemiology studies and genome-wide association scans, in particular, routinely involve
massive testing. These studies have uncovered many robustly replicating genetic variants that are
predictors of susceptibility to complex diseases. It is also apparent that the vast majority of
genetic variants carry effect sizes, such as measured by log(OR), that are very close to zero, and
there are commonly only a handful of variants with odds ratios as large as 1.5. This implies tiny
values of s20. For example, a reported distribution of effect sizes for the bipolar disorder
7 and
cancers8 translates into the values of the order 10−6 to 10−5 for s20 (Methods section). In this
paper, we show how small values of s20 render P-intervals unfit as a measure of Prep variability and
provide an alternative solution based on a Mixture Bayesian approach, which is not constrained
to the conjugate model only and provides a researcher with the flexibility to specify any desired
prior effect size distribution. Our results reveal immunity of the Mixture Bayes-based intervals
to selection bias and multiple testing phenomena. We contrast the performance of the traditional
P-intervals relative to the Bayesian-based prediction intervals using results from the Psychiatric
Genomics Consortium (PGS)4 and conclude with a discussion of the implications of our findings.
Methods
Prediction intervals
The P-interval can be obtained as a classical prediction interval for the normally distributed test
statistics, (Z-statistics). The prediction distribution for the statistic Zrep that relates to the one-
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sided P-value as Prep = 1 − Φ(Zrep) is the normal, Φ(zobt, 2), where Φ(·) is the standard normal
cumulative distribution function (CDF). This distribution does not depend on the actual mean
of Z, which is
√
N × δ. The reason for that becomes apparent when the P-interval is derived as
a Bayesian prediction interval. For a normally distributed Z-statistic, Z ∼ N(µ, 1), assume the
conjugate model, that is, µ ∼ √N × Φ(m0, s20). Then the posterior distribution for the mean of
Zobt is normal Φ(θ, s
2), where
θ | Zobt =
m0√
Ns20
+ Zobt
s2
(1)
s2 | Zobt =
[
1
Ns20
+ 1
]−1
, (2)
and the prediction distribution for Zrep is Φ(θ, 1+s
2). Thus, the P-interval based on the distribution
Φ(zobt, 2) is a Bayesian interval that implicitly assumes that N×s20 →∞. We refer to the resulting
intervals as the Conjugate Bayes intervals. The endpoints of these intervals are given by
θ ± z(1−α/2)
√
s2 + 1 (3)
≡ Zobt σ
2
0
1 + σ20
+
m0
1 + σ20
± z(1−α/2)
√
1 +
σ20
1 + σ20
, (4)
where z(1−α/2) is the 1 − α/2 quantile of the standard normal distribution and σ20 = Ns20. The
conjugate model is restrictive in that a specific prior distribution has to be assumed, which may
not provide an adequate representation of external knowledge about the effect size distribution.
It also limits construction of the intervals to P-values derived from statistics for which there are
known conjugate priors. Here, we introduce a much more flexible approach, the Mixture Bayes,
without these restrictions. The Mixture Bayes intervals can be constructed for P-values derived
from statistics whose distribution is governed by a parameter γ that captures deviation from the
usual point null hypothesis, H0, and has the form
√
N × δ or its square, N × δ2. This includes
normal, chi-squared, Student’s t and F-statistics. We partition the prior distribution of γ into
a finite mixture of values δ1, δ2, . . . , δB with the corresponding prior probabilities, Pr(δi). As an
example, let P-value be derived from an F-test for comparison of two sample means, with the
corresponding sample sizes n1 and n2. Let N = 1/(1/n1 + 1/n2). For i-th prior value of effect, a
statistic based on sampling values of T = (X¯1 − X¯2)2/σˆ2 has a noncentral F distribution, with the
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noncentrality
γi = N [(µ1 − µ2)/σ]2i = Nδ2i , (5)
and the degrees of freedom df1 = 1,df2 = n1 + n2 − 2:
T ∼ f(T = t | γi, df1, df2), (6)
where f is the density of the noncentral F-distribution. The posterior distribution is a mixture,
Pr(δ2j | T = t) =
Pr(δ2j )f(T = t | γj , df1,df2)∑B
i=1 Pr(δ
2
i )f(T = t | γi, df1, df2)
, (7)
with the posterior mean
θ =
B∑
i=1
δ2i Pr(δ
2
i | P-value). (8)
Next, we obtain the CDF of the prediction distribution for the replication statistic, Trep, as
Fp(x) =
B∑
j
Pr(δ2j | Tobt)
∫ x
0
f(Trep | γj , df1,df2)dTrep
=
B∑
j
Pr(δ2j | Tobt)F (Trep = x | γj , df1,df2). (9)
Then, the Mixture Bayes interval endpoints are derived from the quantiles of this CDF, that are
given by F−1p (x).
Prior variance for the standardized logarithm of the odds ratio
Genetic epidemiology and other observational studies routinely test hypotheses conceptually related
to a comparison of two sample means. Effect size is often measured by the log of odds ratio, which
can be related to the difference in means (that become frequencies, p1 and p2, in the case of binary
variables) as p1 − p2 ≈ log(OR) p˜(1− p˜), where p˜ is the pooled frequency. Distribution of P-values
for commonly used test statistics depends on the product of the sample size, (N or
√
N), and a
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measure of effect size, µ, scaled by the variance σ2 (or σ), i.e. δ = µ/σ. For example, when the
outcome is a case/control classification and the predictor is also binary, the standardized effect size
can be expressed in terms of the correlation (R) times the sample size as follows:
γ =
√
N × µ
σ
=
√
N × δ =
√
N ×R
=
√
N × p1 − p2√
p˜(1− p˜) [v(1− v)]−1
, (10)
(11)
where v is the proportion of cases in the sample. In terms of the logarithm of the odds ratio, OR,
γ =
√
N × δ =
√
N × log(OR)√
1
v
1
p1(1−p1) +
1
1−v
1
p2(1−p2)
(12)
≈
√
N × log(OR)√
[p˜(1− p˜)v(1− v)]−1
. (13)
For a given value of OR, the standardized effect size δ cannot exceed the value δmax(OR) that we
obtained by maximizing the right hand side of Equ. (12) as:
δmax(OR) =
ln(OR)
2
√
2 + 1+OR√
OR
. (14)
Let F−1(· | µ0, s20) denote the inverse CDF of the conjugate prior distribution. Writing Pr(OR ≥
x) = β and assuming a symmetric distribution of the effect size around zero, i.e., m0 = 0, we can
relate the value δmax to the prior variance of the conjugate model in the following way:
δmax(OR) =
√
s20 F
−1(1− β | 0, 1).
The maximum spread for the conjugate prior distribution is therefore obtained when its variance
is equal to
s20 =
[
δmax(OR)
F−1(1− β | 0, 1)
]2
. (15)
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It should be noted that Equ. 14 gives the maximum δ value for a given value of OR, however it
is not monotone in OR. The maximum possible value of δmax(OR) can be found to be at OR ≈
121.35. Curiously, this value of OR implies δmax(OR) value equal to the Laplace Limit constant,
0.662743...
Park et al.8 reported distribution of effect sizes for breast, prostate and colorectal (BPC) cancers
in terms of a table, giving the numbers of different loci (Li) with the corresponding values of ORi.
Using the same approach, Chen et al.7 provided the effect size distribution for the bipolar disorder
(BP) risk loci. Assuming the total number of independent variants to be M=300 000, proportions
of associated loci are wi = Li/M . We assumed the average OR among non-associated loci to
be 1.005 (or its inverse for the negative part of the log(OR) distribution). The variance s20 was
calculated as
∑
iwi(γi/
√
2N −mw)2, where mw =
∑
iwiγi/
√
2N , and gave the value ≈ 5 × 10−6
for both cancer and the BP disorder risk loci. Thus, N needs to be about 50 000 for s20 × N to
reach 1/2.
Results
Table 1 summarizes the empirical coverage probabilities of the 80% prediction intervals for a stan-
dardized effect size
√
N × δ under different types of P-value selection (simulation study set up is
detailed in Supplementary Information). The observed P-value was based on a two-sample Z-test
and was thresholded according to the following selection rules: (i) no selection, i.e., a prediction
interval is constructed for a randomly observed P-value; (ii) selection of P-values around a value,
e.g., P ≈ 0.05, i.e., prediction intervals are constructed only for P-values that were close to the
5% significance level; (iii) selection of P-values that are smaller than a threshold, e.g., P < 0.05.
The empirical coverage was calculated based on 50 000 simulations using three different methods:
(a) a conjugate Bayesian model assuming normal prior distribution for the observed value of a test
statistic, Zobt ∼ Φ(0, σ20), where σ20 = s20×N ; (b) our Mixture Bayes approach with the same prior
as for the conjugate model; and (c) the original P-interval proposed by Cumming.1
Mixture Bayes intervals were included in these simulations to check how well they approximate
a continuous prior distribution assumed by the conjugate intervals. We used mixture components
with the length σ0/8 for every component and truncated the normal prior at 10
−6 and 1 − 10−6
8
quantiles. This provided us with sufficient accuracy and resulted in the number of mixture compo-
nents, B, equal to 76 for all values of σ20.
Table 1 clearly indicates that all three construction methods have the correct coverage (∼80%)
if a prediction interval is calculated for a randomly observed P-value ∈ [0, 1]. However, selection
and small prior variance both impair performance of P-intervals. For instance, if an interval is
constructed for a P-value < 0.001 and σ20 = 0.25, the coverage of the traditional non-Bayesian
P-interval may be as low as 17%. Even for large values of prior σ20, the P-interval has poor coverage
when constructed for P-values around genome-wide significance levels (e.g., P-value < 1.5× 10−7).
Similar conclusions regarding the coverage can be drawn if a prediction interval is constructed
for the most significant P-value out of L tests (Table 2). Specifically, both Bayesian methods have
the correct coverage and are immune to the selection bias. The non-Bayesian P-interval approach,
however, once again performs poorly if the prior variance is small. Additionally, as the number of
tests increases, out of which a minimum P-value is selected, the P-interval coverage is becoming
increasingly off the 80% mark.
We next explored the effect of prior variance mis-specification on the coverage of the Bayesian-
type prediction interval when it is constructed for the most significant result out of L tests. Two
scenarios were considered: under-specification (σ20/2) and over-specification (2σ
2
0) of the prior vari-
ance σ20 = Ns
2
0. The results are summarized in Table 3 and indicate that in terms of the coverage
it is safer to over-specify values of the prior variance than to under-specify them. The conjugate
model with m0 = 0 gives the intervals in the following form
Zobt
σ20
1 + σ20
± z(1−α/2)
√
1 +
σ20
1 + σ20
, (16)
indicating that σ20 values that are too small pull the interval mean excessively toward zero while at
the same time reducing its proper length.
Unlike the regular Bayesian model, our Mixture Bayes approach is not limited to conjugate
priors and prediction intervals can be constructed for any P-value stemming from statistics other
than the normal Z-test. Additionally, the Mixture Bayes approach allows the use of any prior
distribution and enjoys the same coverage properties as the conjugate-Bayes prediction intervals,
that is, resistance to multiple testing and selection bias (Supplementary Tables S1 and S2).
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To illustrate the interpretation of the prediction intervals, we replicated part of Table 1 in Lazze-
roni et al.,4 who considered recent findings from the Psychiatric Genomics Consortium (PGC) for
attention deficit-hyperactivity disorder (ADHD), autism spectrum disorder (ASD), bipolar disorder
(BPD), major depressive disorder (MDD) and schizophrenia. The consortium reported four single
nucleotyde polymorphisms (SNPs) associated with these psychiatric disorders but, for illustrative
purposes, we constructed prediction intervals only for a single SNP, rs2535629. We used four differ-
ent methods to calculate prediction intervals: (i) the conjugate Bayesian model with the estimated
prior variance, s20, based on the results from Chen et al.
7 (see Methods section); (ii) Mixture Bayes
approximation to this continuous conjugate normal prior, using the same variance, s20; (iii) Mixture
Bayes approach with the BP effect size distribution reported in Chen et al. as a prior (without
assuming the conjugate model); and (iv) prediction intervals suggested by Lazzeroni et al. (which
are equivalent to Cumming’s P-intervals for one-sided P-values).
Table 4 summarizes the results. Due to our usage of intervals for one-sided P-values in the
last column of our Table 4, there is a discrepancy with the prediction intervals given in Table 1 of
Lazzeroni et al. For instance, for the ADHD disorder, Lazzeroni and colleagues provided prediction
interval bounds of (0.00, 4.29). These values can be easily recovered from Table 4 by subtracting
logarithm based ten of two from both prediction interval bounds (e.g., 4.29 = 4.59 − log10(2)).
For all psychiatric disorders, lower bounds of the 95% prediction intervals for P-values based on
the approach suggested by Lazzeroni et al.4 are smaller (or larger in terms of the -log10(P-value)
interval) than the ones from the Bayesian-based methods. For instance, Lazzeroni and colleagues
concluded that in a similarly powered replication of the original PGC design, a P-value for an
association between rs2535629 and ADHD could be as low as 2.5×10−5, given the observed P-value
of 0.1005. Our interval results portray a less optimistic picture with the P-value lower bound for
ADHD equal to 0.02. Similar observations hold for psychiatric disorders with significant observed
P-values. For example, in Lazzeroni et al. the bipolar disorder is concluded to be likely to yield a
P-value < 10−8 for rs2535629, reaching genome-wide significance at a replication study. Mixture
Bayes prediction interval based on the reported effect size distribution7 suggests a higher lower
bound for the BP replication P-value of 6.9 × 10−7. The difference highlights the implicit prior
assumption built into the P-intervals that large effect sizes are as likely as small a priori.
Nonetheless, similar to conclusions in Lazzeroni et al., the association of rs2535629 with BP
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appears to be a promising signal. Also, similarly to the conclusions in Lazzeroni et al., the combined
study of all psychiatric disorders is predicted to perform better than replication studies of individual
phenotypes.
While it is expected that different diseases would have different effect size distributions, we
wanted to check the robustness of our results to prior mis-specification and utilized available effect
size distribution given in Park et al.8 for cancers. This assumes that the effect size distribution
in terms of odds ratios has common main features for different complex diseases, namely, that it
is L-shaped with the majority of effect sizes that can be attributed to individual SNPs being very
small, and that the frequency of relatively common variants with increasingly large values of OR
quickly dropping to zero for OR as large as about 3. The modified intervals are reported in Table
5. While Mixture Bayes intervals become somewhat different from those derived using the effect
size distribution for BP, their bounds are much more similar to each other than to the bounds of
P-intervals.
Discussion
It can be argued that regardless of the degree of their variability, P-values are poorly suited for what
they are used for in practice. Researchers want to know whether a statistic used for summarizing
their data supports their scientific hypothesis and to what degree. P-values in general do not reflect
uncertainty about a hypothesis. This point and other misconceptions have been recently reviewed
in a statement on statistical significance and P-values by the American Statistical Association.9
Here, we focused specifically on variability of P-values in replication studies. We examined implicit
prior assumptions of previously suggested methods and detailed how these assumptions can be
explicitly stated in terms of the distribution of the effect size. As an intermediate step of our
approach, fully Bayesian posterior distributions for standardized parameters, such as (µ1 − µ2)/σ,
are readily extractable from P-values that originate from many basic and widely used test statistics,
including the normal Z-statistics, Student’s t-test statistics, chi-square and F-statistics.
Our results show that while P-intervals are derived without the explicit assumption that all
effect sizes are equally likely, such a “flat” prior is assumed implicitly and leads to bias when in
reality the effect size distribution is modeled more realistically, allowing only a small chance to
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encounter a large effect size and supposing that the majority of effect sizes would be small. Many
observational studies seeking associations of health outcomes with environmental exposures and
genetic predictors can be viewed conceptually as a comparison of two sample means, δ = µ1 − µ2.
Presence of a true association in such studies implies a certain difference in mean values of exposure
between subjects with and without disease. In such examples, the prior variance reflects the prior
spread of the mean of a test statistic, which usually can be related to the spread of the standardized
mean difference. The prior spread in units of standard deviation cannot be very large, especially
in the fields of observational sciences, that are currently at the focus of the replicability crisis.
For example, assuming that effect sizes with the odds ratio (OR) greater than three are relatively
rare (1% occurrence rate), the prior variance for ln(OR)/
√
Var(ln(OR)) is about 0.01 at its largest
possible value (Equ. 15) and would typically be smaller.
As we show here, setting the mean of the prediction distribution to zobt in the construction of
P-intervals is equivalent to assuming that any possible value of
√
N×δ is equally likely. This covers
the entire real line (−∞,∞) and can be an extremely strong assumption to make in many epidemi-
ological contexts. As a consequence, interval statements obtained with P-intervals become invalid
when applied to a particular value or a range of P-values (e.g. 0.049 < Pobt < 0.051) and result in
biased intervals. The (1−α) nominal coverage of P-intervals can be Bonferroni-adjusted4 for L tests
as (1 − α/L) and while that procedure can restore the long-run coverage property, the endpoints
of such intervals would still lack interpretation as probability bounds for a replication P-value. On
the other hand, Bayesian prediction intervals that acknowledge the actual variability in the possi-
ble values of the effect size do depend on the sample size and have correct coverage regardless of
whether a selection of P-values is present. Reanalysis of the intervals reported by Lazzeroni and
colleagues4 shows that P-intervals can be substantially different from Bayesian prediction intervals,
even when sample sizes are very large (Table 4). These results also reflect discrepancies obtained
with the direct, “as is” usage of the estimated prior distribution in the Mixture Bayes approach
and an attempt to approximate this distribution by the conjugate prior with the same variance.
Endpoints of the conjugate intervals on the log scale are comparatively shorter and highlight lack
of flexibility inherent in the conjugate approximation to the prior: allowance for a large fraction of
effect sizes to be close to zero makes the tails of the conjugate distribution too thin. The estimated
prior distribution used by the Mixture Bayes approach is more fat-tailed and is also asymmetric
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due to a high proportion of minor alleles that carry effects of the positive sign.
Bayesian prediction intervals require informed input about various values of the effect size and
their respective frequencies. This is not impossible. We know, for example, that in genetic associ-
ation studies, the squared effect size distribution is L-shaped, where the majority of genetic effects
across the genome are tiny and only few are large. We should contrast such a prior distribution,
even if specified only approximately, with a largely unrealistic assumption implicit in P-intervals.
When the assumed prior distribution does in fact follow reality, Bayesian prediction intervals enjoy
the property of being resistant to the winner’s curse. One can select P-values in any range and
obtain unbiased intervals or select the minimum P-value from an experiment with however many
tests: the resulting interval would still be unbiased without the need of a multiple-testing adjust-
ment to its coverage level. P-intervals are a special case of our Mixture Bayes intervals, and can be
obtained by specifying the prior distribution for δ as a zero-mean normal with the prior variance
s20 such that σ
2
0 = N × s20 is very large. When P-values are selected based on a cut-off value or
their magnitude, P-intervals can still be a poor approximation to a distribution with σ20 as large as
10. For example, the last row of Table 2 demonstrates that P-intervals are still biased for σ20 = 10
in terms of the coverage when constructed for the minimum P-value taken from multiple-testing
experiments with 10,000 tests. Multiple-testing on the scale of genome-wide studies would further
degrade the coverage of P-intervals. Using the commonly used asymptotically normal statistic for
odds ratio as an example, we emphasize that the standardized values δ can be bounded, and in this
case, the bounds (L,U) are approximately −0.66 < δ < 0.66. This places specific restrictions on
how large s20 can be. For the zero-mean normal prior, s0=0.66/3 is still unreasonably large, and in
general, even for prior distributions concentrated at these bounds, s20 ≤ (U −L)2/4 by Popoviciu’s
inequality.
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Tables
Type of P-value selection Prior variance (σ20) Conjugate Bayes Mixture Bayes P-interval
0 ≤ P-value ≤ 1 0.25 80.1% 80.2% 80.2%
(no selection) 0.50 80.0% 80.0% 79.9%
1.00 80.0% 80.0% 80.0%
3.00 80.4% 80.4% 80.4%
5.00 80.2% 80.2% 80.3%
10.00 80.1% 80.1% 80.1%
0.045 ≤ P-value ≤ 0.055 0.25 79.8% 79.8% 58.4%
0.50 80.1% 80.1% 66.7%
1.00 79.8% 79.8% 73.5%
3.00 80.0% 80.0% 80.2%
5.00 79.9% 79.9% 80.7%
10.00 80.1% 80.1% 80.8%
0 ≤ P-value ≤ 0.05 0.25 80.0% 80.0% 46.0%
0.50 80.1% 80.1% 55.4%
1.00 80.2% 80.2% 65.5%
3.00 79.8% 79.8% 75.7%
5.00 80.4% 80.4% 78.4%
10.00 80.3% 80.3% 79.5%
0 ≤ P-value ≤ 0.001 0.25 80.1% 80.1% 17.0%
0.50 80.1% 80.1% 29.7%
1.00 80.0% 79.9% 47.6%
3.00 80.0% 80.0% 70.2%
5.00 79.9% 79.9% 75.4%
10.00 79.7% 79.8% 78.2%
5× 10−8 ≤ P-value ≤ 1.5× 10−7 3.00 80.1% 80.1% 62.8%
5.00 79.5% 79.5% 72.6%
10.00 79.8% 79.8% 78.3%
5× 10−9 ≤ P-value ≤ 1.5× 10−8 3.00 80.0% 80.0% 60.6%
5.00 79.9% 80.0% 71.8%
10.00 80.2% 80.2% 78.1%
Table 1: The empirical coverage probabilities of the 80% prediction intervals for a two-sample Z-test.
The table illustrates the effect of the observed P-value thresholding, e.g., selection of statistically
significant P-values at 5% level, on the empirical coverage.
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Number of tests Prior variance (σ20) Conjugate Bayes Mixture Bayes P-interval
L = 10 0.25 80.4% 80.4% 63.8%
0.50 79.9% 79.9% 66.2%
1.00 80.6% 80.6% 70.4%
3.00 80.0% 80.0% 75.1%
5.00 80.1% 80.1% 76.7%
10.00 80.1% 80.1% 78.3%
L = 100 0.25 79.8% 79.8% 35.7%
0.50 80.2% 80.2% 42.3%
1.00 79.9% 79.9% 51.1%
3.00 79.6% 79.6% 65.1%
5.00 80.0% 80.0% 70.0%
10.00 79.8% 79.8% 74.5%
L = 1, 000 0.25 80.0% 80.1% 16.9%
0.50 79.9% 79.8% 23.9%
1.00 80.0% 79.9% 35.0%
3.00 80.0% 79.9% 55.5%
5.00 79.7% 79.6% 63.1%
10.00 80.2% 80.1% 70.7%
L = 10, 000 0.25 80.1% 80.1% 07.2%
0.50 80.1% 80.0% 12.9%
1.00 79.8% 79.6% 23.1%
3.00 79.7% 79.1% 46.2%
5.00 80.2% 79.6% 56.5%
10.00 80.2% 79.5% 66.5%
Table 2: The empirical coverage probabilities of the 80% prediction intervals for a two-sample Z-
test. The table illustrates the effect of selecting the most significant P-value (out of L test) on the
P-interval coverage.
Number of tests Prior variance (σ20) Bayes (σ
2
0/2) Bayes (2σ
2
0) P-interval
L = 1 0.5 77.5% 81.7% 80.3%
1 76.5% 81.5% 79.7%
L = 10 0.25 77.6% 81.1% 63.8%
0.5 75.9% 80.8% 66.2%
L = 100 3 70.4% 77.8% 65.1%
1 72.1% 77.2% 51.1%
L = 1000 0.25 76.4% 78.2% 16.9%
0.5 72.9% 75.8% 23.9%
L = 10 000 3 62.0% 72.9% 46.2%
10 69.5% 77.1% 66.5%
Table 3: The effect of the prior variance misspecification on the coverage of the Bayesian-type
prediction interval.
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SNP Disorder Cases Controls One-sided P-value Prediction intervals, − log10 P
Conjugate Bayes† Mixture Bayes† Mixture Bayes‡ Lazerroni et al.
rs2535629 ADHD 2787 2635 0.1005 (0.01, 1.63) (0.01, 1.63) (0.01, 1.64) (0.03, 4.59)
ASD 4949 5314 0.098 (0.01, 1.66) (0.01, 1.66) (0.01, 1.66) (0.03, 4.62)
BP 6990 4820 3.305e-06 (0.01, 1.77) (0.01, 1.77) (0.03, 6.16) (1.38, 12.77)
MDD 9227 7383 0.000108 (0.01, 1.80) (0.01, 1.80) (0.02, 5.28) (0.75, 10.31)
Schizophrenia 9379 7736 3.355e-05 (0.01, 1.82) (0.01, 1.82) (0.02, 6.40) (0.95, 11.16)
All 33 332 27 888 1.27e-12 (0.06, 2.93) (0.06, 2.91) (4.83, 17.65) (4.93, 22.13)
Table 4: Revised predictions based on recent results from the Psychiatric Genomics Consortium4
with the prior effect size distribution estimated for the bipolar disorder susceptibility loci.7 Ab-
breviations: ADHD, attention deficit-hyperactivity disorder; ASD, autism spectrum disorder; BP,
bipolar disorder; MDD, major depressive disorder. †The prior effect size distribution using the
conjugate model with the variance estimated based on the tabulated values of effect sizes reported
in Chen et al.7 ‡The prior effect size distribution specified directly by the estimates reported in
Chen et al.7
SNP Disorder Cases Controls One-sided P-value Prediction intervals, − log10 P
Conjugate Bayes† Mixture Bayes† Mixture Bayes‡ Lazerroni et al.
rs2535629 ADHD 2787 2635 0.1005 (0.01, 1.63) (0.01, 1.63) (0.01, 1.63) (0.03, 4.59)
ASD 4949 5314 0.098 (0.01, 1.66) (0.01, 1.66) (0.01, 1.66) (0.03, 4.62)
BP 6990 4820 3.305e-06 (0.01, 1.76) (0.01, 1.76) (0.03, 8.23) (1.38, 12.77)
MDD 9227 7383 0.000108 (0.01, 1.80) (0.01, 1.80) (0.01, 4.13) (0.75, 10.31)
Schizophrenia 9379 7736 3.355e-05 (0.01, 1.82) (0.01, 1.82) (0.02, 6.03) (0.95, 11.16)
All 33 332 27 888 1.27e-12 (0.06, 2.89) (0.06, 2.89) (4.37, 19.05) (4.93, 22.13)
Table 5: Revised predictions based on recent results from the Psychiatric Genomics Consortium4
with the prior effect size distribution estimated for cancer risk loci.8 Abbreviations: ADHD, at-
tention deficit-hyperactivity disorder; ASD, autism spectrum disorder; BP, bipolar disorder; MDD,
major depressive disorder. †The prior effect size distribution using the conjugate model with the
variance estimated based on the tabulated values of effect sizes reported in Park et al.8 ‡The prior
effect size distribution specified directly by the estimates reported in Park et al.8
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Supplementary Information
Simulations
A statement where Pobt is given any value, such as 0.05, is a type of selection that induces selection
bias, commonly described as the winner’s curse. Our simulations are designed to demonstrate
that sort of bias for P-intervals. On the other hand, when we are equipped with knowledge about
the actual underlying effect size distribution, the resulting intervals are expected to be immune
to selection bias. The most straightforward scenario is to restrict computation of the intervals to
P-values in a narrow interval around a value, such as 0.05, and see empirically what the actual
coverage is, compared to the declared 80%. We proceeded with this scenario as follows. Let the
prior distribution for the mean of a Z-statistic be µ ∼ √NΦ(m0, s20). In our simulations we set
m0 = 0. Simulation steps are as follows:
1. Draw a value of µ from its assumed distribution. Simulate data by taking two samples of
normal observations with the population means 0 and µ and compute a Z-statistic, zobt (this
step can be simplified by drawing zobt directly from Φ(µ, 1)). Calculate the P-value, Pobt,
from zobt. If Pobt does not fall within a specified range, e.g., 0.045 to 0.055, discard zobt.
Repeat this step until Pobt falls within the predefined range.
2. Simulate data as in the previous step or draw zrep directly from Φ(µ, 1).
3. Calculate the P-interval using the prediction distribution Φ(zobt, 2). Check whether the repli-
cation value falls within the interval.
4. Calculate Bayesian prediction intervals and check whether the replication value falls within
these interval.
Next, we repeat the above steps 50,000 times. At the end, we calculate the proportion of times
when the replication value was within the studied intervals.
We studied two additional types of P-value selection: (i) inclusion of P-values that are smaller
than a predefined threshold, that is, we kept only those P-values that are less than some value, e.g.
Pobt ≤ 0.05; (ii) selection of the minimum P-value from a multiple testing experiment with L tests
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(in this modification we draw L statistics zobt and keep the maximum one that corresponds to the
smallest P-value).
Supplementary tables
Type of P-value selection Prior variance (σ20) Mixture Bayes coverage
0 ≤ P-value ≤ 1 0.25 79.7%
(no selection) 0.50 79.8%
1.00 80.1%
3.00 80.1%
5.00 79.9%
10.00 79.9%
0.045 ≤ P-value ≤ 0.055 0.25 79.4%
0.50 79.7%
1.00 80.5%
3.00 80.5%
5.00 80.7%
10.00 79.5%
0 ≤ P-value ≤ 0.05 0.25 79.9%
0.50 79.7%
1.00 80.7%
3.00 79.7%
5.00 80.0%
10.00 79.9%
0 ≤ P-value ≤ 0.001 0.25 79.9%
0.50 79.0%
1.00 80.2%
3.00 80.5%
5.00 79.9%
10.00 79.6%
Table S1: The empirical coverage probabilities of the 80% mixture-Bayes prediction intervals for a
two-sample t-test under selection of P-values.
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Number of tests Prior variance (σ20) Mixture Bayes coverage
L = 10 0.25 79.2%
0.50 79.9%
1.00 80.3%
3.00 79.8%
5.00 80.1%
10.00 79.3%
L = 100 0.25 80.3%
0.50 79.9%
1.00 79.9%
3.00 80.7%
5.00 80.1%
10.00 80.4%
L = 1000 0.25 79.1%
0.50 80.0%
1.00 80.4%
3.00 80.1%
5.00 79.9%
10.00 79.9%
L = 10 000 0.25 79.6%
0.50 80.2%
1.00 79.2%
3.00 79.8%
5.00 79.9%
10.00 79.3%
Table S2: The empirical coverage probabilities of the 80% mixture-Bayes prediction intervals con-
structed for the most significant results out of L two-sample t-tests.
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